HYUNDAI BIOSCIENCE Designates Call Option Holders for CBs to Secure Management Control, Limited Impact on Shareholder Value
HYUNDAI BIOSCIENCE designated call option holders for approximately 11.67% of its 10 billion KRW 12th unsecured private convertible bonds, selecting five related parties including major shareholder C&P.
The purpose is to secure management stability by enabling early repurchase of the CBs, thereby preventing dilution from conversion.
The CBs have a conversion price of 10,201 KRW per share and would issue only 114,368 shares, representing 0.12% of outstanding shares, so dilution impact is minimal.
However, the call option exercise price includes a premium above 104% of principal, implying a cost for the buyers, and the concentration of call rights among insiders raises governance concerns for minority shareholders.
[AI Summary]The designation of call options to related parties aims to strengthen management control, but the negligible dilution of 0.12% and defensive nature of the move suggest limited near-term impact on shareholder value. Neutral vigilance regarding governance and cash outflows if options are exercised is warranted.
KOSDAQ Filing Information
Report on Major Events (Designation of Person Exercising Call Option for Convertible Bonds)